The safety and toxicity of phage therapy: a review of animal and clinical studies D Liu, JD Van Belleghem, CR de Vries, E Burgener, Q Chen, ... Viruses 13 (7), 1268, 2021 | 170 | 2021 |
Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients D Kang, AV Revtovich, Q Chen, KN Shah, CL Cannon, NV Kirienko Frontiers in microbiology 10, 2048, 2019 | 101 | 2019 |
Pf bacteriophage and their impact on Pseudomonas virulence, mammalian immunity, and chronic infections PR Secor, EB Burgener, M Kinnersley, LK Jennings, V Roman-Cruz, ... Frontiers in immunology 11, 244, 2020 | 87 | 2020 |
Antimicrobial activity of ibuprofen against cystic fibrosis-associated gram-negative pathogens PN Shah, KR Marshall-Batty, JA Smolen, JA Tagaev, Q Chen, ... Antimicrobial agents and chemotherapy 62 (3), 10.1128/aac. 01574-17, 2018 | 57 | 2018 |
A filamentous bacteriophage protein inhibits type IV pili to prevent superinfection of Pseudomonas aeruginosa AK Schmidt, AD Fitzpatrick, CM Schwartzkopf, DR Faith, LK Jennings, ... MBio 13 (1), e02441-21, 2022 | 37 | 2022 |
Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics Q Chen, T Dharmaraj, PC Cai, EB Burgener, NL Haddock, AJ Spakowitz, ... Pharmaceutics 14 (7), 1425, 2022 | 32 | 2022 |
Minocycline and Silver Dual-Loaded Polyphosphoester-Based Nanoparticles for Treatment of Resistant Pseudomonas aeruginosa Q Chen, KN Shah, F Zhang, AJ Salazar, PN Shah, R Li, JC Sacchettini, ... Molecular pharmaceutics 16 (4), 1606-1619, 2019 | 25 | 2019 |
Filamentous bacteriophage delays healing of Pseudomonas-infected wounds MS Bach, CR de Vries, A Khosravi, JM Sweere, MC Popescu, Q Chen, ... Cell reports Medicine 3 (6), 2022 | 22 | 2022 |
Phages in vaccine design and immunity; mechanisms and mysteries CR de Vries, Q Chen, S Demirdjian, G Kaber, A Khosravi, D Liu, ... Current opinion in biotechnology 68, 160-165, 2021 | 21 | 2021 |
A filamentous bacteriophage protein inhibits type IV pili to prevent superinfection of Pseudomonas aeruginosa. mBio 13: e0244121 AK Schmidt, AD Fitzpatrick, CM Schwartzkopf, DR Faith, LK Jennings, ... | 11 | 2022 |
Pf bacteriophage and their impact on Pseudomonas virulence, mammalian immunity, and chronic infections. Front Immunol 11: 244 PR Secor, EB Burgener, M Kinnersley, LK Jennings, V Roman-Cruz, ... | 8 | 2020 |
Hetero-Multivalent Targeted Liposomal Drug Delivery to Treat Pseudomonas aeruginosa Infections A Singla, SB Simbassa, B Chirra, A Gairola, MR Southerland, KN Shah, ... ACS Applied Materials & Interfaces 14 (36), 40724-40737, 2022 | 7 | 2022 |
Filamentous bacteriophages and the competitive interaction between Pseudomonas aeruginosa strains under antibiotic treatment: a modeling study JD Pourtois, MJ Kratochvil, Q Chen, NL Haddock, EB Burgener, ... Msystems 6 (3), 10.1128/msystems. 00193-21, 2021 | 7 | 2021 |
N-acetyl cysteine abrogates silver-induced reactive oxygen species in human cells without altering silver-based antimicrobial activity KN Shah, PN Shah, AR Mullen, Q Chen, MR Southerland, B Chirra, ... Toxicology letters 332, 118-129, 2020 | 7 | 2020 |
Rapid assessment of changes in phage bioactivity using dynamic light scattering T Dharmaraj, MJ Kratochvil, JD Pourtois, Q Chen, M Hajfathalian, A Hargil, ... PNAS nexus 2 (12), pgad406, 2023 | 6 | 2023 |
Synergistic antimicrobial effects of ibuprofen combined with standard-of-care antibiotics against cystic fibrosis pathogens Q Chen, M Ilanga, SB Simbassa, B Chirra, KN Shah, CL Cannon Biomedicines 11 (11), 2936, 2023 | 5 | 2023 |
A filamentous bacteriophage protein inhibits type IV pili to prevent superinfection of Pseudomonas aeruginosa. mBio 13: e02441-21 AK Schmidt, AD Fitzpatrick, CM Schwartzkopf, DR Faith, LK Jennings, ... | 3 | 2022 |
Phage Therapy for Respiratory Infections: Opportunities and Challenges A Khosravi, Q Chen, A Echterhof, JL Koff, PL Bollyky Lung, 1-10, 2024 | 2 | 2024 |
Antimicrobial activity of a natural compound and analogs against multi-drug-resistant Gram-positive pathogens KN Shah, PN Shah, FO Agobe, K Lovato, H Gao, O Ogun, C Hoffman, ... Microbiology Spectrum 12 (3), e01515-22, 2024 | 2 | 2024 |
BACTERIA-SPECIFIC DRUG DELIVERY: HETERO-MULTIVALENT TARGETED LIPOSOMES FOR TREATMENT OF PSEUDOMONAS AERUGINOSA SB Simbassa, A Singla, KN Shah, Q Chen, B Chirra, N Dangol, R Raina, ... PEDIATRIC PULMONOLOGY 54, S266-S267, 2019 | 1 | 2019 |